RT Conference Proceedings
T1 Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
A1 Isla, D.
A1 Arriola, E.
A1 Garcia Campelo, M. R.
A1 Marti, C.
A1 Diz Tain, P.
A1 Moreno Vega, A. L.
A1 Piqueras, M. L-B.
A1 Leon, L.
A1 Gutierrez Calderon, V.
A1 Oramas Rodriguez, J. M.
A1 Majem, M.
A1 Sanchez-Hernandez, A.
A1 Aguado de la Rosa, C.
A1 Alvarez Cabellos, R.
A1 Marti-Ciriquian, J. L.
A1 Moreno Paul, A.
A1 Gonzalez Cordero, M.
A1 Callejo Mellen, A.
A1 Baez, L.
A1 Zugazagoitia, J.
PB Elsevier
SN 0923-7534
YR 2022
FD 2022-04-02
LK http://hdl.handle.net/10668/21893
UL http://hdl.handle.net/10668/21893
LA en
DS RISalud
RD Apr 11, 2025